The Metagenomic Sequencing Market Report provides forecasts and analyses for the global and regional metagenomic sequencing markets. The study provides historical data from 2016 and revenue projections from 2019 to 2025. (USD Million). The study examines the market drivers and restraints for metagenomic sequencing, as well as their impact on demand over the forecast period. In addition, the report investigates global and regional market opportunities for metagenomic sequencing.
In order to provide readers with a thorough understanding of the metagenomic sequencing market, we have included a competitive landscape and Porter’s Five Forces analysis. The study includes an analysis of market attractiveness, in which all segments are compared based on market size, growth rate, and overall attractiveness.
The report provides a market share analysis of key players in the metagenomic sequencing market in order to provide a comprehensive overview of the competitive landscape. In addition, the report covers key strategic developments of the market, such as acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of key players involved in the global and regional metagenomic sequencing market.
By segmenting the metagenomic sequencing market based on workflow, product and service, technology, application, and region, the study offers a definitive perspective on the market. All market segments for metagenomic sequencing have been analysed based on current and projected demand and market trends, and the market from 2019 to 2025 has been forecasted.
Metagenomics is the study of environmental samples containing genetic material. For population analysis of unidentified microorganisms, metagenomics techniques are utilised. The discovery of previously unknown microorganisms opens up new avenues for the study of virology, ecology, environmental sciences, microbiology, biomedical research, and so on. Metagenomic sequencing is a more recent technique used to examine thousands of organisms in parallel and systematically sample all genes, which provides valuable insights into the biodiversity and function of a community.
The market for metagenomics sequencing is driven by its diverse applications in fields such as drug discovery, ecology, virology, the environment, and industrial applications, among others. In addition, government initiatives and funding for large-scale sequencing projects, as well as decreasing sequencing costs, drive the growth of the metagenomics sequencing market. However, a lack of trained professionals and budgetary concerns in developing regions may impede this market’s expansion. The availability of cloud-based data management solutions is anticipated to create new opportunities for metagenomics sequencing market participants.
The global metagenomic sequencing market is segmented by product and service into instruments, reagents & consumables, analysis & data interpretation solutions, and services. In 2018, the segment of reagents and consumables held the largest market share due to their popularity in metagenomic sequencing projects. Technological advancements play a significant role in driving demand for new and advanced instruments, whereas cost-effective outsourcing services are anticipated to fuel the segment’s high growth over the forecast period.
The workflow segment of the global market for metagenomic sequencing comprises data processing and analysis, sequencing, and sample processing and library preparation. The segment of sample processing & library preparation held the largest market share in 2018, while the segment of sequencing workflow is anticipated to grow at the highest CAGR during the forecast period.
This rapid expansion is supported by developments in next-generation sequencing techniques. It is anticipated that a lack of qualified professionals will contribute to the sluggish growth of the data processing and analysis workflow segment over the forecast period.
The technology segment consists of 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing & de novo assembly, and metatranscriptomics. The segment of shotgun metagenomic sequencing is anticipated to record the highest CAGR during the forecast period.
Based on application, the market is divided into Clinical diagnostics, drug discovery, soil microbiome applications, environmental and ecological applications, veterinary applications, and other applications. In 2018, the drug discovery application segment accounted for the largest market share, whereas the clinical diagnostics and industrial applications segments are anticipated to experience the highest growth over the forecast period.
The metagenomic sequencing market discusses the current and forecasted demand for regions such as Middle East & Africa, North America, Asia Pacific, Latin America, and Europe. In 2018, North America held the largest share of the global market for metagenomic sequencing. This region’s market growth is supported by the presence of developed research and development infrastructure, government funding, and increasing public and private investment in NGS projects. Due to rising investments in next-generation sequencing technologies and favourable government funding, Europe occupied the second-leading position on the market. The Asia-Pacific region is anticipated to experience the greatest growth during the forecast period, as major players concentrate their efforts on emerging markets such as India, China, etc.
The report includes Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer, QIAGEN N.V., BGI Group, Oxford Nanopore Technologies Ltd., GENEWIZ, Eurofins Scientific, Macrogen Inc., Zymo Research Corporation, Novogene Corporation, IntegraGen SA, NuGEN Technologies, Inc., DNAStar, Inc., and Microsynth AG as major market participants.